Funding Opportunity PAR-21-157 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit an Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD)-focused U01 that is ancillary to, but integrated with, the Midlife in the United States Study (MIDUS) U19 to provide in-depth information to elucidate behavioral, social, psychological and biological pathways of risk and resilience to cognitive decline and AD/ADRD.

Notice NOT-GM-21-023 from the NIH Guide for Grants and Contracts

Notice NOT-GM-21-024 from the NIH Guide for Grants and Contracts

Notice NOT-GM-21-017 from the NIH Guide for Grants and Contracts

Notice NOT-MH-21-150 from the NIH Guide for Grants and Contracts

Notice NOT-NS-21-031 from the NIH Guide for Grants and Contracts

Notice NOT-NS-21-032 from the NIH Guide for Grants and Contracts

Negotiable: Paramount Recruitment: Bioinformatics Pipeline Developer Cambridge This is a great opportunity for a strong Bioinformatics Pipeline Developer to join the R&D Computatio Cambridge, England

Negotiable: Paramount Recruitment: Bioinformatics Pipeline Developer Cambridge This is a great opportunity for a strong Bioinformatics Pipeline Developer to join the R&D Computatio Cambridge, England

Experience with statistical data analysis using data analysis tools (e.g. Evaluates data using probability statistics and trend analysis. What We Can Offer You:
From CACI - Thu, 25 Feb 2021 11:12:44 GMT - View all Morgantown, WV jobs

The shift will help researchers who change their names midcareer, including transgender scientists

Funding Opportunity RFA-HL-22-003 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to serve as the Data Coordinating Center (DCC) that will support the activities of the Lung Transplant Consortium (LTC). The primary responsibility of the DCC will be to oversee the conduct of multiple observational clinical studies involving lung transplantation in the LTC. The DCC will support regulatory and administrative activities, data and biospecimen collection and management, statistical analyses, and the reporting of study results in a timely manner. The DCC will promote collaboration and communication among LTC investigators and the broader research community and will coordinate outreach activities including engaging foundations, societies, and other entities with a shared interest in lung transplantation. The DCC will be responsible for integrating the efforts of approximately 24 individual LTC Clinical Centers performing observational research studies to identify factors that impact donor lung utilization and the development of acute lung allograft dysfunction in lung transplant recipients. The NHLBI anticipates that the DCC will collaborate strategically with the LTC Clinical Centers to provide support for protocol development, statistical data analyses, biospecimen collection and storage, the publication of results, and providing datasets for secondary analyses by the broader research community. This FOA runs in parallel with a separate FOA that invites applications for the LTC Clinical Centers, described in detail in RFA-HL-22-002

Funding Opportunity RFA-HL-22-002 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks applications from lung transplant clinical centers (CCs) to form a cooperative multi-site Lung Transplant Consortium (LTC). The LTC will support CCs in conducting observational and complementary mechanistic clinical research studies that aim to understand the impact of site-specific lung transplant selection criteria and clinical management strategies on donor lung utilization and/or early post-transplant outcomes such as the development of primary graft dysfunction (PGD) and acute lung allograft dysfunction (ALAD) in recipients. Each CC application must consist of a multidisciplinary investigative team that includes a lung transplant surgeon and a lung transplant pulmonologist, and be comprised of primary and subsites that have a combined annual lung transplant volume of at least 100 transplants. Each CC application should propose hypothesis-driven scientific questions to assess certain donor and/or recipient clinical practices and their impact on donor lung utilization, PGD, ALAD or other relevant short-term outcomes that can be addressed through observational data and/or biospecimen collection and analysis at the sites included in their application. In addition, the CCs will be expected to enroll participants and contribute to a core set of data and biospecimens to be collected across all participating consortium sites through the implementation of a common research protocol under the auspices of a centralized Data Coordinating Center (DCC) and a Steering Committee (SC). By leveraging this shared longitudinal resource, LTC investigators will have the tools to identify and answer additional important research questions involving lung transplantation. This FOA runs in parallel with a separate FOA that invites applications for the LTC Data Coordinating Center, solicited under RFA-HL-22-003.

Notice NOT-GM-21-019 from the NIH Guide for Grants and Contracts

Notice NOT-AR-21-014 from the NIH Guide for Grants and Contracts

Notice NOT-AR-21-013 from the NIH Guide for Grants and Contracts

Notice NOT-DA-21-031 from the NIH Guide for Grants and Contracts

This Ph.D. student struggled with self-doubt until she adopted a strategy inspired by one of her favorite performers

Notice NOT-AI-21-037 from the NIH Guide for Grants and Contracts

Notice NOT-AI-21-038 from the NIH Guide for Grants and Contracts